FibroGen, Inc.FGENNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
46.06
↓ 84% below average
Average (9y)
290.87
Historical baseline
Range
High:683.66
Low:46.06
CAGR
-17.3%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 46.06 | -2.6% |
| 2023 | 47.28 | -82.2% |
| 2022 | 265.85 | +92.6% |
| 2021 | 138.04 | -70.6% |
| 2020 | 468.91 | +29.6% |
| 2019 | 361.75 | -20.8% |
| 2018 | 456.75 | -33.2% |
| 2017 | 683.66 | +266.6% |
| 2016 | 186.50 | -26.5% |
| 2015 | 253.86 | - |